DBVT Q4 2020 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$1M-172.5% YoY

Gross Profit

-$1M100.0% margin

Operating Income

-$40M3313.6% margin

Net Income

-$39M3257.8% margin

EPS (Diluted)

$-3.60

QoQ Revenue Growth

-129.1%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$272M

Total Liabilities

$67M

Stockholders' Equity

$205M

Cash & Equivalents

$196M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$1M	$2M	-172.5%
Gross Profit	-$1M	$2M	-172.5%
Operating Income	-$40M	-$46M	+12.4%
Net Income	-$39M	-$47M	+16.8%